                         SEQUENCE LISTING

<110>  Ichor Therapeutics
       Moody, Kelsey
 
<120>  IMPROVING ENZYME AUGMENTATION THERAPIES BY MODIFYING 
       GLYCOSYLATION

<130>  P265042.WO.01

<150>  US 62/635,333
<151>  2018-02-26

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Unknown


<220>
<221>  misc_feature
<222>  (2)..(2)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (5)..(5)
<223>  Xaa can be any naturally occurring amino acid

<400>  1

Asn Xaa Ser Asn Xaa Thr Cys 
1               5           


<210>  2
<211>  378
<212>  PRT
<213>  Phanerochaete chrysosporium

<400>  2

Met Ala Phe Lys Ser Leu Ile Ala Phe Val Ala Leu Ala Ala Ala Val 
1               5                   10                  15      


Arg Ala Ala Pro Thr Ala Val Cys Pro Asp Gly Thr Arg Val Ser His 
            20                  25                  30          


Ala Ala Cys Cys Ala Phe Ile Pro Leu Ala Gln Asp Leu Gln Glu Thr 
        35                  40                  45              


Ile Phe Gln Asn Glu Cys Gly Glu Asp Ala His Glu Val Ile Arg Leu 
    50                  55                  60                  


Thr Phe His Asp Ala Ile Ala Ile Ser Arg Ser Gln Gly Pro Lys Ala 
65                  70                  75                  80  


Gly Gly Gly Ala Asp Gly Ser Met Leu Leu Phe Pro Thr Val Glu Pro 
                85                  90                  95      


Asn Phe Ser Ala Asn Asn Gly Ile Asp Asp Ser Val Asn Asn Leu Ile 
            100                 105                 110         


Pro Phe Met Gln Lys His Asn Thr Ile Ser Ala Ala Asp Leu Val Gln 
        115                 120                 125             


Phe Ala Gly Ala Val Ala Leu Ser Asn Cys Pro Gly Ala Pro Arg Leu 
    130                 135                 140                 


Glu Phe Leu Ala Gly Arg Pro Asn Lys Thr Ile Ala Ala Val Asp Gly 
145                 150                 155                 160 


Leu Ile Pro Glu Pro Gln Asp Ser Val Thr Lys Ile Leu Gln Arg Phe 
                165                 170                 175     


Glu Asp Ala Gly Gly Phe Thr Pro Phe Glu Val Val Ser Leu Leu Ala 
            180                 185                 190         


Ser His Ser Val Ala Arg Ala Asp Lys Val Asp Gln Thr Ile Asp Ala 
        195                 200                 205             


Ala Pro Phe Asp Ser Thr Pro Phe Thr Phe Asp Thr Gln Val Phe Leu 
    210                 215                 220                 


Glu Val Leu Leu Lys Gly Val Gly Phe Pro Gly Ser Ala Asn Asn Thr 
225                 230                 235                 240 


Gly Glu Val Ala Ser Pro Leu Pro Leu Gly Ser Gly Ser Asp Thr Gly 
                245                 250                 255     


Glu Met Arg Leu Gln Ser Asp Phe Ala Leu Ala His Asp Pro Arg Thr 
            260                 265                 270         


Ala Cys Ile Trp Gln Gly Phe Val Asn Glu Gln Ala Phe Met Ala Ala 
        275                 280                 285             


Ser Phe Arg Ala Ala Met Ser Lys Leu Ala Val Leu Gly His Asn Arg 
    290                 295                 300                 


Asn Ser Leu Ile Asp Cys Ser Asp Val Val Pro Val Pro Lys Pro Ala 
305                 310                 315                 320 


Thr Gly Gln Pro Ala Met Phe Pro Ala Ser Thr Gly Pro Gln Asp Leu 
                325                 330                 335     


Glu Leu Ser Cys Pro Ser Glu Arg Phe Pro Thr Leu Thr Thr Gln Pro 
            340                 345                 350         


Gly Ala Ser Gln Ser Leu Ile Ala His Cys Pro Asp Gly Ser Met Ser 
        355                 360                 365             


Cys Pro Gly Val Gln Phe Asn Gly Pro Ala 
    370                 375             


